Chenyi Lin, MD, Phd

Endocrinologist
Stanford Univeristy School of Medicine
Palo Alto, California, United States

Disclosure information not submitted.

Presentation(s):

• SUN-400 - Euglycemic Diabetic Ketoacidosis After Teprotumumab: A De Novo Presentation of Type 1 Diabetes

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT